Alpha-1 adrenergic receptor, Beta-1 adrenergic receptor, and Beta-2 adrenergic receptor (α1-adrenergic receptor (α1-AR), β1-adrenergic receptor (β1-AR), β2-adrenergic receptor (β2-AR))

Alpha-1, beta-1, and beta-2 adrenergic receptors are distinct members of the adrenergic receptor family, all of which are G protein-coupled receptors (GPCRs) that mediate the physiological effects of catecholamines, such as norepinephrine and epinephrine[2][5][6]. Alpha-1 receptors (primarily coupled to Gq proteins) mediate vasoconstriction and smooth muscle contraction[4][5]. Beta-1 receptors (Gs protein-coupled) regulate cardiac inotropy and chronotropy and stimulate renin release in the kidney[1][7]. Beta-2 receptors (also Gs-coupled) are key for smooth muscle relaxation, especially in bronchi, as well as vasodilation and metabolic regulation[2][5]. These receptors play pivotal roles in cardiovascular, pulmonary, and metabolic physiology, are major drug targets, and are implicated in a wide range of diseases and therapeutic interventions ranging from hypertension and heart failure to asthma, shock, and others[1][2][4][6].

Other names

Alpha-1 receptor (α1 receptor)Beta-1 receptor (β1 receptor)Beta-2 receptor (β2 receptor)Adrenergic receptor subtypesAdrenoceptors

Agonists: Stimulate receptor activity to mimic effects of endogenous catecholamines (epinephrine, norepinephrine). Antagonists: Block receptor activity, reducing sympathetic outflow or action. Inverse agonists: Reduce basal receptor activity below constitutive levels.